Exogenous leptin protects rat models of sodium taurocholate‑induced severe acute pancreatitis through endocrinal and immunological pathways

Qi,Haiyu; Lu,Qin; Yin,Chenghong; Xiao,Hongli; Wen,Yan; Zhang,Shuwen; Cui,Qu; Yang,Wei

doi:10.3892/mmr.2017.7320

Exogenous leptin protects rat models of sodium taurocholate‑induced severe acute pancreatitis through endocrinal and immunological pathways

Authors:
- Haiyu Qi
- Qin Lu
- Chenghong Yin
- Hongli Xiao
- Yan Wen
- Shuwen Zhang
- Qu Cui
- Wei Yang
View Affiliations

Affiliations: Department of Rheumatology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Immunology, School of Basic Medicine, Norman Bethune Health Science Center, Jilin University, Changchun 130021, P.R. China
Published online on: August 22, 2017 https://doi.org/10.3892/mmr.2017.7320
Pages: 6306-6312

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute pancreatitis (AP) is a common non‑bacterial disease compromising pancreatic tissues. Adipocyte‑derived leptin is closely associated with the severity and clinical outcome of pancreatitis. The potential protective effects of exogenous leptin administration on a rat model of severe AP (SAP) remain to be elucidated, and were examined in the present study. Male Wistar rats were divided into a sham operation group (SO), SAP model group (SAP) and leptin group (LEP). Each group was divided into three sub‑groups by observation time (24, 48 and 72 h). The SAP models were prepared by retrograde injection of 6% sodium taurocholate into the pancreatic‑bile duct. Following model establishment, exogenous leptin was intraperitoneally injected into mice at 50 mg/kg in the LEP group. Subsequently, serum amylase, lipase and glucose levels at particular time‑points were analyzed using a fully‑automatic biochemical analyzer, and serum levels of tumor necrosis factor (TNF)‑α and interleukin (IL)‑10 were detected using an enzyme‑linked immunosorbent assay. The pathological changes in pancreatic tissues were observed using hematoxylin and eosin staining, and the pancreatic expression of the long form of the leptin receptor (OB‑Rb) was detected and evaluated using Nest‑polymerase chain reaction analysis. The mortality rates of the model rats were compared between the groups. Following the administration of exogenous leptin, the serum level of amylase in the LEP group was significantly decreased at 48 h, compared with that in the SAP group, with serum lipase levels decreased at 48 and 72 h, and blood glucose levels decreased at 72 h. Regarding the serum inflammatory factors, the level of TNF‑α in the LEP group was significantly lower, compared with that in the SAP group at 24 h; whereas no significant difference was observed in the serum level of IL‑10 between the two groups. Regarding the pathological changes in the pancreas, the tissues in the LEP group showed significantly alleviated pancreatic inflammation. In addition, the pancreatic expression of OB‑Rb in the LEP group was significantly higher, compared with that in the SAP group at 24 and 48 h. No significant difference in 3‑day mortality rates were observed between the SAP group and the LEP group. Taken together, exogenous leptin administration regulated inflammatory factors and the expression of OB‑Rb at the early stage of AP, which exerted protective effects by through the immunological and endocrinal pathways.

View Figures

View References

1	Sarr MG, Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Tsiotos GG and Vege SS: The new revised classification of acute pancreatitis 2012. Surg Clin North Am. 93:549–562. 2013. View Article : Google Scholar : PubMed/NCBI
2	Dedemadi G, Nikolopoulos M, Kalaitzopoulos I and Sgourakis G: Management of patients after recovering from acute severe biliary pancreatitis. World J Gastroenterol. 22:7708–7717. 2016. View Article : Google Scholar : PubMed/NCBI
3	Wang GJ, Gao CF, Wei D, Wang C and Ding SQ: Acute pancreatitis: Etiology and common pathogenesis. World J Gastroenterol. 15:1427–1430. 2009. View Article : Google Scholar : PubMed/NCBI
4	Jaworek J, Bonior J, Pierzchalski P, Tomaszewska R, Stachura J, Sendur R, Leja A, Jachimczak B, Konturek PC, Bielański W, et al: Leptin protects the pancreas from damage induced by caerulein overstimulation by modulating cytokine production. Pancreatology. 2:89–99. 2002. View Article : Google Scholar : PubMed/NCBI
5	Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A and Dixit VD: Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology. 152:4039–4045. 2011. View Article : Google Scholar : PubMed/NCBI
6	Jaworek J and Konturek SJ: Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin. World J Gastroenterol. 20:16902–16912. 2014. View Article : Google Scholar : PubMed/NCBI
7	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
8	Yavuz N, Unal E, Memisoglu K, Krand O, Kiziler AR, Aydemir B, Kusaslan R, Dogan M, Gunes P and Titiz I: Plasma leptin levels in rats with pancreatitis. Tohoku J Exp Med. 204:243–248. 2004. View Article : Google Scholar : PubMed/NCBI
9	Konturek PC, Jaworek J, Maniatoglou A, Bonior J, Meixner H, Konturek SJ and Hahn EG: Leptin modulates the inflammatory response in acute pancreatitis. Digestion. 65:149–160. 2002. View Article : Google Scholar : PubMed/NCBI
10	Yu P, Wang S, Qiu Z, Bai B, Zhao Z, Hao Y, Wang Q, Guo M, Feng X, Zhu J, et al: Efficacy of resistin and leptin in predicting persistent organ failure in patients with acute pancreatitis. Pancreatology. 16:952–957. 2016. View Article : Google Scholar : PubMed/NCBI
11	Warzecha Z, Dembinski A, Ceranowicz P, Jaworek J, Konturek PC, Dembiński M, Bilskl J and Konturek SJ: Influence of leptin administration on the course of acute ischemic pancreatitis. J Physiol Pharmacol. 53:775–790. 2002.PubMed/NCBI
12	Warzecha Z, Dembinski A, Ceranowicz P, Dembiński M, Cieszkowski J, Kuśnierz-Cabala B, Naskalski JW, Jaworek J, Konturek SJ, Pawlik WW and Tomaszewska R: Influence of ischemic preconditioning on blood coagulation, fibrinolytic activity and pancreatic repair in the course of caerulein-induced acute pancreatitis in rats. J Physiol Pharmacol. 58:303–319. 2007.PubMed/NCBI
13	Liang HY, Chen T, Wang T, Huang Z, Yan HT and Tang LJ: Time course of intestinal barrier function injury in a sodium taurocholate-induced severe acute pancreatitis in rat model. J Dig Dis. 15:386–393. 2014. View Article : Google Scholar : PubMed/NCBI
14	Mo J, Yang A, Chen Z, Shao T, Zhang Y and Chen Q: Neuronostatin ameliorates sodium taurocholate-induced acute pancreatitis in rats. Dig Dis Sci. 58:2903–2907. 2013. View Article : Google Scholar : PubMed/NCBI
15	Kusske AM, Rongione AJ, Ashley SW, McFadden DW and Reber HA: Interleukin-10 prevents death in lethal necrotizing pancreatitis in mice. Surgery. 120:284–289. 1996. View Article : Google Scholar : PubMed/NCBI
16	Chen Y, Lu W, Gao N, Long Y, Shao Y, Liu M, Chen H, Ye S, Ma X, Liu M and Li D: Generation of obese rat model by transcription activator-like effector nucleases targeting the leptin receptor gene. Sci China Life Sci. 60:152–157. 2017. View Article : Google Scholar : PubMed/NCBI
17	Jaworek J, Bonior J, Nawrot K, Leja A, Sendur R, Stachura J, Pawlik W and Konturek S: Intracerebroventricular administration of bacterial lipopolysaccharide prevents the development of acute experimental pancreatitis in the rat. Med Sci Monit. 8:BR136–BR143. 2002.PubMed/NCBI
18	Kennedy JI, Askelund KJ, Premkumar R, Phillips AR, Murphy R, Windsor JA and Petrov MS: Leptin is associated with persistence of hyperglycemia in acute pancreatitis. Medicine (Baltimore). 95:e23822016. View Article : Google Scholar : PubMed/NCBI
19	Lee Y, Wang MY, Kakuma T, Wang ZW, Babcock E, McCorkle K, Higa M, Zhou YT and Unger RH: Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem. 276:5629–5635. 2001. View Article : Google Scholar : PubMed/NCBI
20	Cheung CC, Thornton JE, Nurani SD, Clifton DK and Steiner RA: A reassessment of leptin's role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology. 74:12–21. 2001. View Article : Google Scholar : PubMed/NCBI
21	Norman J: The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 175:76–83. 1998. View Article : Google Scholar : PubMed/NCBI
22	Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA and McFadden DW: Interleukin 10 reduces the severity of acute pancreatitis in rats. Gastroenterology. 112:960–967. 1997. View Article : Google Scholar : PubMed/NCBI
23	Rongione AJ, Kusske AM, Reber HA, Ashley SW and McFadden DW: Interleukin-10 reduces circulating levels of serum cytokines in experimental pancreatitis. J Gastrointest Surg. 1:159–166. 1997. View Article : Google Scholar : PubMed/NCBI
24	Rongione AJ, Kusske AM, Ashley SW, Reber HA and McFadden DW: Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. J Surg Res. 70:107–112. 1997. View Article : Google Scholar : PubMed/NCBI
25	Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA and McFadden DW: Interleukin-10 protects against lethality of intra-abdominal infection and sepsis. J Gastrointest Surg. 4:70–76. 2000. View Article : Google Scholar : PubMed/NCBI
26	Jaworek J, Bonio J, Leja-Szpa A, Nawrot K, Tomaszewska MR, Stachura J, Pawlik WW and Konturek SJ: Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin. J Physiol Pharmacol. 53:51–74. 2002.PubMed/NCBI
27	Emilsson V, Liu YL, Cawthorne MA, Morton NM and Davenport M: Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes. 46:313–316. 1997. View Article : Google Scholar : PubMed/NCBI
28	Jin L, Burguera BG, Couce ME, Scheithauer BW, Lamsan J, Eberhardt NL, Kulig E and Lloyd RV: Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role for leptin on pituitary cell proliferation. J Clin Endocrinol Metab. 84:2903–2911. 1999. View Article : Google Scholar : PubMed/NCBI
29	Paz-Filho G, Mastronardi C, Wong ML and Licinio J: Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J Endocrinol Metab. 16 Suppl 3:S549–S555. 2012. View Article : Google Scholar : PubMed/NCBI
30	Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR and Grunfeld C: Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol. 276:R136–R142. 1999.PubMed/NCBI